株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

バイオマーカーの世界市場:市場規模・現状・将来予測 (2019~2025年)

Global Biomarkers Market Size, Status and Forecast 2019-2025

発行 QYResearch 商品コード 793453
出版日 ページ情報 英文 56 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=110.56円で換算しております。
Back to Top
バイオマーカーの世界市場:市場規模・現状・将来予測 (2019~2025年) Global Biomarkers Market Size, Status and Forecast 2019-2025
出版日: 2019年11月12日 ページ情報: 英文 56 Pages
概要

世界のバイオマーカーの市場規模は、2019年には4億0873万米ドル、2025年には10億5618万米ドルと、14.6%のCAGR (複合年間成長率) で拡大する見通しです。

当レポートでは、世界のバイオマーカー市場について分析し、業界の基本構造や背景事情・最新情勢、全体的な市場規模の動向見通し (過去5年間・今後7年間分)、種類別・用途別および地域別の詳細動向、主要企業のプロファイル・業績、今後の市場成長の可能性・方向性などを調査しております。

第1章 分析概要

  • 分析範囲
  • 主な市場区分
  • 分析対象企業
  • 種類別の市場区分
    • 市場規模・成長率:種類別 (今後7年間分)
    • 敗血症バイオマーカー
    • 抗生物質耐性バイオマーカー
    • 外傷性脳損傷 (TBI) 検査用バイオマーカー
    • 脳卒中検査用バイオマーカー
    • 抗菌薬適正使用支援 (AS) 用バイオマーカー
  • 用途別の市場区分
    • 市場シェア:用途別 (今後7年間分)
    • 診断
    • 創薬
    • 個別化医療
  • 分析対象
  • 分析期間

第2章 敗血症バイオマーカーの市場分析

  • 市場規模:地域別 (通算12年間分)
  • 市場規模:企業別
    • 米国の主要企業
    • 欧州の主要企業
    • 中国の主要企業
    • 日本の主要企業
  • 企業合併・買収 (M&A)、事業拡張計画

第3章 抗生物質耐性バイオマーカーの市場分析

第4章 外傷性脳損傷 (TBI) 検査用バイオマーカーの市場分析

第5章 脳卒中検査用バイオマーカーの市場分析

第6章 抗菌薬適正使用支援 (AS) 用バイオマーカーの市場分析

第7章 アナリストの見解/結論

第8章 付録

図表

List of Tables and Figures

  • Table Biomarkers Key Market Segments 1
  • Table Revenue of Biomarkers Key Players Covered in 2018 (M USD) 2
  • Table Global Biomarkers Market Size Growth Rate by Type (2019-2025) (M USD) 3
  • Figure Global Biomarkers Market Share by Type in 2018 3
  • Figure Global Biomarkers Market Share by Type in 2025 4
  • Table of Key Players of Sepsis Biomarkers 4
  • Table of Key Players of Antibiotic Resistance Biomarkers 5
  • Table of Key Players of Traumatic Brain Injury (TBI) Testing Biomarkers 6
  • Table of Key Players of Stroke Testing Biomarkers 6
  • Table of Key Players of Antibiotic Stewardship Biomarkers 7
  • Table Global Biomarkers Market Size Growth by Application (2019-2025) (M USD) 8
  • Figure Global Biomarkers Market Share by Application in 2018 8
  • Figure Global Biomarkers Market Share by Application in 2025 9
  • Figure Diagnostics Case Studies 9
  • Figure Drug Discovery Case Studies 10
  • Figure Personalized Medicine Case Studies 11
  • Figure Biomarkers Report Years Considered 12
  • Table Global Sepsis Biomarkers Market Size by Region (2014-2019) (M USD) 13
  • Table Global Sepsis Biomarkers Market Size by Region (2020-2025) (M USD) 13
  • Table Global Sepsis Biomarkers Revenue by Player (2018-2019) (M USD) 13
  • Table United States Key Players Sepsis Biomarkers Revenue (2018-2019) (M USD) 14
  • Table Europe Key Players Sepsis Biomarkers Revenue (2018-2019) (M USD) 14
  • Table China Key Players Sepsis Biomarkers Revenue (2018-2019) (M USD) 15
  • Table Japan Key Players Sepsis Biomarkers Revenue (2018-2019) (M USD) 15
  • Table Mergers & Acquisitions, Expansion Plans 16
  • Table Global Antibiotic Resistance Biomarkers Market Size by Region (2014-2019) (M USD) 19
  • Table Global Antibiotic Resistance Biomarkers Market Size by Region (2020-2025) (M USD) 19
  • Table Global Antibiotic Resistance Biomarkers Revenue by Player (2018-2019) (M USD) 19
  • Table United States Key Players Antibiotic Resistance Biomarkers Revenue (2018-2019) (M USD) 20
  • Table Europe Key Players Antibiotic Resistance Biomarkers Revenue (2018-2019) (M USD) 21
  • Table China Key Players Antibiotic Resistance Biomarkers Revenue (2018-2019) (M USD) 21
  • Table Japan Key Players Antibiotic Resistance Biomarkers Revenue (2018-2019) (M USD) 22
  • Table Mergers & Acquisitions, Expansion Plans 22
  • Table Global Traumatic Brain Injury (TBI) Testing Biomarkers Market Size by Region (2014-2019) (M USD) 27
  • Table Global Traumatic Brain Injury (TBI) Testing Biomarkers Market Size by Region (2020-2025) (M USD) 27
  • Table Global Traumatic Brain Injury (TBI) Testing Biomarkers Revenue by Player (2018-2019) (M USD) 27
  • Table United States Key Players Traumatic Brain Injury (TBI) Testing Biomarkers Revenue (2018-2019) (M USD) 28
  • Table Europe Key Players Traumatic Brain Injury (TBI) Testing Biomarkers Revenue (2018-2019) (M USD) 28
  • Table Mergers & Acquisitions, Expansion Plans 29
  • Table Global Stroke Testing Biomarkers Market Size by Region (2014-2019) (M USD) 30
  • Table Global Stroke Testing Biomarkers Market Size by Region (2020-2025) (M USD) 30
  • Table Global Stroke Testing Biomarkers Revenue by Player (2018-2019) (M USD) 30
  • Table United States Key Players Stroke Testing Biomarkers Revenue (2018-2019) (M USD) 31
  • Table Europe Key Players Stroke Testing Biomarkers Revenue (2018-2019) (M USD) 31
  • Table China Key Players Stroke Testing Biomarkers Revenue (2018-2019) (M USD) 32
  • Table Japan Key Players Stroke Testing Biomarkers Revenue (2018-2019) (M USD) 32
  • Table Mergers & Acquisitions, Expansion Plans 32
  • Table Global Antibiotic Stewardship Biomarkers Market Size by Region (2014-2019) (M USD) 36
  • Table Global Antibiotic Stewardship Biomarkers Market Size by Region (2020-2025) (M USD) 36
  • Table Global Antibiotic Stewardship Biomarkers Revenue by Player (2018-2019) (M USD) 36
  • Table United States Key Players Antibiotic Stewardship Biomarkers Revenue (2018-2019) (M USD) 37
  • Table Europe Key Players Antibiotic Stewardship Biomarkers Revenue (2018-2019) (M USD) 37
  • Table China Key Players Antibiotic Stewardship Biomarkers Revenue (2018-2019) (M USD) 38
  • Table Japan Key Players Antibiotic Stewardship Biomarkers Revenue (2018-2019) (M USD) 38
  • Table Mergers & Acquisitions, Expansion Plans 39
  • Table Research Programs/Design for This Report 43
  • Figure Bottom-up and Top-down Approaches for This Report 45
  • Figure Data Triangulation 46
  • Figure Key Executives Interviewed 47
  • Table Key Data Information from Secondary Sources 48
  • Table Key Data Information from Primary Sources 48
目次

In 2018, the global Biomarkers market size was 40.873 billion US$ and it is expected to reach 105.618 billion US$ by the end of 2025, with a CAGR of 14.6% during 2019-2025.

This report focuses on the global Biomarkers status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Biomarkers development in United States, Europe, China, Japan, and Other Regions

The key players covered in this study:

  • Thermo Fisher Scientific
  • Merck
  • Bio-Rad Laboratories
  • QIAGEN
  • Roche
  • Danaher Corporation
  • Siemens Healthcare
  • Abbott
  • Agilent Technologies

Market segment by Type, the product can be split into:

  • Sepsis Biomarkers
  • Antibiotic Resistance Biomarkers
  • Traumatic Brain Injury (TBI) Testing Biomarkers
  • Stroke Testing Biomarkers
  • Antibiotic Stewardship Biomarkers
  • Others

Market segment by Application, split into:

  • Diagnostics
  • Drug Discovery
  • Personalized Medicine
  • Others

Market segment by Regions/Countries, this report covers:

  • United States
  • Europe
  • China
  • Japan
  • Other Regions

Table of Contents

1 Report Overview 1

  • 1.1 Study Scope 1
  • 1.2 Key Market Segments 1
  • 1.3 Players Covered 2
  • 1.4 Market Analysis by Type 2
    • 1.4.1 Global Biomarkers Market Size Growth Rate by Type (2019-2025) 2
    • 1.4.2 Sepsis Biomarkers 4
    • 1.4.3 Antibiotic Resistance Biomarkers 5
    • 1.4.4 Traumatic Brain Injury (TBI) Testing Biomarkers 5
    • 1.4.5 Stroke Testing Biomarkers 6
    • 1.4.6 Antibiotic Stewardship Biomarkers 7
  • 1.5 Market by Application 7
    • 1.5.1 Global Biomarkers Market Share by Application (2019-2025) 8
    • 1.5.2 Diagnostics 9
    • 1.5.3 Drug Discovery 10
    • 1.5.4 Personalized Medicine 11
  • 1.6 Study Objectives 11
  • 1.7 Years Considered 12

2 Sepsis Biomarkers Market Analysis 13

  • 2.1 Sepsis Biomarkers Market Size by Region (2014-2025) 13
  • 2.2 Global Sepsis Biomarkers Market Size by Player (2018-2019) 13
    • 2.2.1 Sepsis Biomarkers Key Players in United States 14
    • 2.2.2 Sepsis Biomarkers Key Players in Europe 14
    • 2.2.3 Sepsis Biomarkers Key Players in China 15
    • 2.2.4 Sepsis Biomarkers Key Players in Japan 15
  • 2.3 Mergers & Acquisitions, Expansion Plans 16

3 Antibiotic Resistance Biomarkers Market Analysis 19

  • 3.1 Antibiotic Resistance Biomarkers Market Size by Region (2014-2025) 19
  • 3.2 Global Antibiotic Resistance Biomarkers Market Size by Player (2018-2019) 19
    • 3.2.1 Antibiotic Resistance Biomarkers Key Players in United States 20
    • 3.2.2 Antibiotic Resistance Biomarkers Key Players in Europe 21
    • 3.2.3 Antibiotic Resistance Biomarkers Key Players in China 21
    • 3.2.4 Antibiotic Resistance Biomarkers Key Players in Japan 22
  • 3.3 Mergers & Acquisitions, Expansion Plans 22

4 Traumatic Brain Injury (TBI) Testing Biomarkers Market Analysis 27

  • 4.1 Traumatic Brain Injury (TBI) Testing Biomarkers Market Size by Region (2014-2025) 27
  • 4.2 Global Traumatic Brain Injury (TBI) Testing Biomarkers Market Size by Player (2018-2019) 27
    • 4.2.1 Traumatic Brain Injury (TBI) Testing Biomarkers Key Players in United States 28
    • 4.2.2 Traumatic Brain Injury (TBI) Testing Biomarkers Key Players in Europe 28
  • 4.3 Mergers & Acquisitions, Expansion Plans 29

5 Stroke Testing Biomarkers Market Analysis 30

  • 5.1 Stroke Testing Biomarkers Market Size by Region (2014-2025) 30
  • 5.2 Global Stroke Testing Biomarkers Market Size by Player (2018-2019) 30
    • 5.2.1 Stroke Testing Biomarkers Key Players in United States 31
    • 5.2.2 Stroke Testing Biomarkers Key Players in Europe 31
    • 5.2.3 Stroke Testing Biomarkers Key Players in China 32
    • 5.2.4 Stroke Testing Biomarkers Key Players in Japan 32
  • 5.3 Mergers & Acquisitions, Expansion Plans 32

6 Antibiotic Stewardship Biomarkers Market Analysis 36

  • 6.1 Antibiotic Stewardship Biomarkers Market Size by Region (2014-2025) 36
  • 6.2 Global Antibiotic Stewardship Biomarkers Market Size by Player (2018-2019) 36
    • 6.2.1 Antibiotic Stewardship Biomarkers Key Players in United States 37
    • 6.2.2 Antibiotic Stewardship Biomarkers Key Players in Europe 37
    • 6.2.3 Antibiotic Stewardship Biomarkers Key Players in China 38
    • 6.2.4 Antibiotic Stewardship Biomarkers Key Players in Japan 38
  • 6.3 Mergers & Acquisitions, Expansion Plans 39

7 Analyst's Viewpoints/Conclusions 42

8 Appendix 43

  • 8.1 Research Methodology 43
    • 8.1.1 Methodology/Research Approach 43
    • 8.1.2 Data Source 47
  • 8.2 Disclaimer 49
  • 8.3 Author Details 50
Back to Top